BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 22993484)

  • 1. Meta-analysis of association between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 gene and diabetic retinopathy in Caucasians and Asians.
    Ma J; Li Y; Zhou F; Xu X; Guo G; Qu Y
    Mol Vis; 2012; 18():2352-60. PubMed ID: 22993484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of peroxisome proliferator-activated receptor γ Pro12Ala gene polymorphism with type 2 diabetic nephropathy risk in Caucasian population.
    Zhou TB; Guo XF; Yin SS
    J Recept Signal Transduct Res; 2014 Jun; 34(3):180-4. PubMed ID: 24329532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2 gene on metabolic syndrome risk: a meta-analysis.
    Zhang R; Wang J; Yang R; Sun J; Chen R; Luo H; Liu D; Cai D
    Gene; 2014 Feb; 535(1):79-87. PubMed ID: 24012868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between the PPARγ2 Pro12Ala polymorphism and nephropathy susceptibility in type 2 diabetes: a meta-analysis based on 9,176 subjects.
    Wang L; Teng Z; Cai S; Wang D; Zhao X; Yu K
    Diagn Pathol; 2013 Jul; 8():118. PubMed ID: 23856170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism of Pro12Ala in the peroxisome proliferator-activated receptor gamma2 gene in Iranian diabetic and obese subjects.
    Mirzaei H; Akrami SM; Golmohammadi T; Doosti M; Heshmat R; Nakhjavani M; Amiri P
    Metab Syndr Relat Disord; 2009 Oct; 7(5):453-8. PubMed ID: 19558269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between PPARγ Pro12Ala gene polymorphism and type 2 diabetic nephropathy risk in Asian population: results from a meta-analysis.
    Liu G; Zhou TB; Jiang Z; Zheng D; Yuan F; Li Y; Hu H; Chen Z
    J Recept Signal Transduct Res; 2014 Apr; 34(2):131-6. PubMed ID: 24303936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between PPARγ2 Pro12Ala polymorphism and type 2 diabetes mellitus in Chinese Han population: a Meta-analysis].
    Tong JY; Huang N; Wang L; Yi YS; Pan XH; Lü Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Apr; 46(4):359-63. PubMed ID: 22800638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 gene might be a risk factor for diabetic retinopathy in Slovene population (Caucasians) with type 2 diabetes and the Pro12Ala polymorphism of the PPARgamma gene is not.
    Petrovic MG; Kunej T; Peterlin B; Dovc P; Petrovic D
    Diabetes Metab Res Rev; 2005; 21(5):470-4. PubMed ID: 15782399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of PPARG Gene Polymorphisms Pro12Ala with Type 2 Diabetes Mellitus: A Meta-analysis.
    Li J; Niu X; Li J; Wang Q
    Curr Diabetes Rev; 2019; 15(4):277-283. PubMed ID: 30207237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Pro12Ala Polymorphism of Peroxisome Proliferator-Activated Receptor gamma 2 (PPARγ2) Gene with Type 2 Diabetes Mellitus in Ethnic Kashmiri Population.
    Majid M; Masood A; Kadla SA; Hameed I; Ganai BA
    Biochem Genet; 2017 Feb; 55(1):10-21. PubMed ID: 27567620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between PPAR-γ2 Pro12Ala polymorphism and obesity: a meta-analysis.
    Yao YS; Li J; Jin YL; Chen Y; He LP
    Mol Biol Rep; 2015 Jun; 42(6):1029-38. PubMed ID: 25502405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-Analysis on the Association of ALDH2 Polymorphisms and Type 2 Diabetic Mellitus, Diabetic Retinopathy.
    Li GY; Li ZB; Li F; Dong LP; Tang L; Xiang J; Li JM; Bao MH
    Int J Environ Res Public Health; 2017 Feb; 14(2):. PubMed ID: 28208752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of genetic polymorphism peroxisome proliferator-activated receptor-gamma2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: Evidence for heterogeneity.
    Radha V; Vimaleswaran KS; Babu HN; Abate N; Chandalia M; Satija P; Grundy SM; Ghosh S; Majumder PP; Deepa R; Rao SM; Mohan V
    Diabetes Care; 2006 May; 29(5):1046-51. PubMed ID: 16644635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association analysis of PPARγ (p.Pro12Ala) polymorphism with type 2 diabetic retinopathy in patients from north India.
    Kaur N; Vanita V
    Ophthalmic Genet; 2017; 38(3):217-221. PubMed ID: 27427939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Pro12Ala polymorphism in peroxisome proliferator activated receptor gamma with proliferative diabetic retinopathy.
    Tariq K; Malik SB; Ali SH; Maqsood SE; Azam A; Muslim I; Khan MS; Azam M; Waheed NK; Qamar R
    Mol Vis; 2013; 19():710-7. PubMed ID: 23559865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT.
    De Cosmo S; Motterlini N; Prudente S; Pellegrini F; Trevisan R; Bossi A; Remuzzi G; Trischitta V; Ruggenenti P;
    Diabetes; 2009 Dec; 58(12):2920-9. PubMed ID: 19720797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala Is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies.
    Zhang H; Zhu S; Chen J; Tang Y; Hu H; Mohan V; Venkatesan R; Wang J; Chen H
    Diabetes Care; 2012 Jun; 35(6):1388-93. PubMed ID: 22619290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism with non-alcoholic fatty liver disease: A meta-analysis.
    Xie R; Tang S; Yang Y
    J Diabetes Complications; 2022 Oct; 36(10):108261. PubMed ID: 36055011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alanine variant of the Pro12Ala polymorphism of the PPARgamma gene might be associated with decreased risk of diabetic retinopathy in type 2 diabetes.
    Malecki MT; Cyganek K; Mirkiewicz-Sieradzka B; Wolkow PP; Wanic K; Skupien J; Solnica B; Sieradzki J
    Diabetes Res Clin Pract; 2008 Apr; 80(1):139-45. PubMed ID: 18077048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARG (Pro12Ala) genetic variant and risk of T2DM: a systematic review and meta-analysis.
    Sarhangi N; Sharifi F; Hashemian L; Hassani Doabsari M; Heshmatzad K; Rahbaran M; Jamaldini SH; Aghaei Meybodi HR; Hasanzad M
    Sci Rep; 2020 Jul; 10(1):12764. PubMed ID: 32728045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.